Universität zu Köln

Emoto, Noriaki ORCID: 0000-0001-6673-2616, Vignon-Zellweger, Nicolas ORCID: 0000-0001-6918-0183, Moreira Lopes, Rheure Alves, Cacioppo, Joseph ORCID: 0000-0002-9763-9139, Desbiens, Louisane, Kamato, Danielle ORCID: 0000-0002-1089-2829, Leurgans, Thomas ORCID: 0000-0001-6912-3699, Moorhouse, Rebecca, Straube, Julia, Wurm, Raphael ORCID: 0000-0003-3027-7775, Heiden, Susi ORCID: 0000-0001-8993-7120, Ergul, Adviye, Yanagisawa, Masashi and Barton, Matthias (2014). 25 Years of endothelin research: the next generation. Life Sci., 118 (2). S. 77 - 87. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1879-0631

Full text not available from this repository.

Abstract

In the past three decades, endothelin and endothelin receptor antagonists have received great scientific and clinical interest, leading to the publication of more than 27,000 scientific articles since its discovery. The Thirteenth International Conference on Endothelin (ET-13) was held on September 8-11, 2013, at Tokyo Campus of the University of Tsukuba in Japan. Close to 300 scientists from 25 countries from around the world came to Tokyo to celebrate the anniversary of the discovery of the endothelin peptide discovered 25 years ago at the University of Tsukuba. This article summarizes some of the highlights of the conference, the anniversary celebration ceremony, and particularly the participation of next generation of endothelin researchers in endothelin science and the anniversary celebration. As a particular highlight, next generation endothelin researchers wrote a haiku (a traditional form of Japanese poetry originating from consisting of no more than three short verses and 27 on, or Japanese phonetic units) to describe the magic of endothelin science which they presented to the conference audience at the anniversary ceremony. The text of each haiku - both in its original language together with the English translation - is part of this article providing in an exemplary fashion how poetry can be bridged with science. Finally, we give an outlook towards the next 25 years of endothelin research. (C) 2014 Elsevier Inc. All rights reserved.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Emoto, Noriaki UNSPECIFIED orcid.org/0000-0001-6673-2616 UNSPECIFIED Vignon-Zellweger, Nicolas UNSPECIFIED orcid.org/0000-0001-6918-0183 UNSPECIFIED Moreira Lopes, Rheure Alves UNSPECIFIED UNSPECIFIED UNSPECIFIED Cacioppo, Joseph UNSPECIFIED orcid.org/0000-0002-9763-9139 UNSPECIFIED Desbiens, Louisane UNSPECIFIED UNSPECIFIED UNSPECIFIED Kamato, Danielle UNSPECIFIED orcid.org/0000-0002-1089-2829 UNSPECIFIED Leurgans, Thomas UNSPECIFIED orcid.org/0000-0001-6912-3699 UNSPECIFIED Moorhouse, Rebecca UNSPECIFIED UNSPECIFIED UNSPECIFIED Straube, Julia UNSPECIFIED UNSPECIFIED UNSPECIFIED Wurm, Raphael UNSPECIFIED orcid.org/0000-0003-3027-7775 UNSPECIFIED Heiden, Susi UNSPECIFIED orcid.org/0000-0001-8993-7120 UNSPECIFIED Ergul, Adviye UNSPECIFIED UNSPECIFIED UNSPECIFIED Yanagisawa, Masashi UNSPECIFIED UNSPECIFIED UNSPECIFIED Barton, Matthias UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-423038
DOI:	10.1016/j.lfs.2014.07.035
Journal or Publication Title:	Life Sci.
Volume:	118
Number:	2
Page Range:	S. 77 - 87
Date:	2014
Publisher:	PERGAMON-ELSEVIER SCIENCE LTD
Place of Publication:	OXFORD
ISSN:	1879-0631
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language CHRONIC KIDNEY-DISEASE; VASOCONSTRICTOR PEPTIDE; RECEPTOR ANTAGONISTS; CLINICAL-TRIALS; NITRIC-OXIDE; DISCOVERY; FUTURE; CELLS; HYPERTENSION; SURVIVAL Multiple languages Medicine, Research & Experimental; Pharmacology & Pharmacy Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/42303